Author:
Lu Zheng,Yang Yonglai,Covington Rae-Ann,Bi Yunxia (Vivian),Dürig Thomas,Ilies Marc A.,Fassihi Reza
Funder
Ashland Specialty Ingredient R&D Pharma
Reference32 articles.
1. Center for Drug Evaluation and Research (CDER), 1995. Guidance for Industry: Immediate Release Solid Oral Dosage Forms Scale-up and Postapproval Changes: Chemistry, Manufacturing, and Controls. In Vitro Dissolution Testing and in Vivo Bioequivalence Documentation. http://www.fda.gov/downloads/Drugs/%E2%80%A6/Guidances/UCM070636.pdf. Accessed Nov 1995.
2. Guidance for Industry: Waiver of in vivo bioavailability and bioequivalence studies for immediate-release solid oral dosage forms based on a biopharmaceutics classification system;Center for Drug Evaluation and Research,2015
3. A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone;Caron;Mol. Pharm.,2011
4. Amorphous solid dispersions of sulfonamide/Soluplus® and sulfonamide/PVP prepared by ball milling;Caron;AAPS PharmSciTech,2013
5. Guar-based monolithic matrix systems: effect of ionizable and non-ionizable substances and excipients on gel dynamics and release kinetics;Dürig;J. Control. Release,2002
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献